Skip to content

Study on the differences of biological characteristics and molecular control mechanism between CD138 positive and CD138 negative cells in multiple myeloma

Study on the differences of biological characteristics and molecular control mechanism between CD138 positive and CD138 negative cells in multiple myeloma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17013883
Enrollment
Unknown
Registered
2017-12-12
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) male and female; 2) diagnosis and recurrence of multiple myeloma patients in the diagnosis and recurrence of IMWG multiple myeloma in 2014; 3) healthy subjects without special physical diseases; 4) the patient or family member has the ability to understand the study and sign the informed consent; 5) carefully cooperate with the doctor to complete the inspection and relevant information.

Exclusion criteria

Exclusion criteria: 1) drug allergies that contain drugs or similar to the chemical structures of the tested drugs in the past; 2) pregnant, lactating women and childbearing patients who are not willing to take contraceptives; 3) patients with drug and long-term drinking that influence the evaluation of test results; 4) patients with mental disorders or other conditions are unable to obtain informed consent and cannot cooperate to complete the requirements of test treatment and inspection procedures; 5) patients receiving organ transplantation; 6) the researchers determined that they are not suitable for attending this study.

Design outcomes

Primary

MeasureTime frame
biological characteristics and molecular control mechanism between CD138 positive and CD138 negative cells;

Countries

China

Contacts

Public ContactShen Jingzhi

The First Affiliated Hospital of Dalian Medical University

sjz060902@sina.com+86 18098875673

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026